Scientists Discover A New Drug That Can Help Treat Alcohol And Tobacco Addiction

Science has left no stone unturned in curing deadly diseases and now it's after addictions as well. According to a latest study there is this new medicine which targets part of the brain’s stress system which can help people with alcohol use disorder (AUD).
Researches done by Raye Litten, from US National Institute on Alcohol Abuse and Alcoholism, conducted a clinical trial of a new compound, called ABT-436, designed to block the effects of vasopressin, a neuropeptide produced in the brain's hypothalamus. "Vasopressin helps to regulate the pituitary adrenal axis and other brain circuits involved in emotion. As such, it plays a role in regulating stress, anxiety and their interaction with AUD," said Litten.
Litten and colleagues recruited 144 alcohol-dependent adult men and women for the 12-week study. During these 28 days, female participants consumed at least 28 drinks per week, while male participants consumed at least 35 drinks per week. Participants were then randomised to receive either placebo tablets or ones containing ABT-436 compound.
Researchers found

 that participants who received ABT-436 refrained alcohol for more days than those who were given the placebo. Participants who reported high levels of stress appeared to respond better to ABT-436. Smokers also benefited from ABT-436. Experts suspect that ABT-436 targeted the same areas in the brain that relate to withdrawal and stress, and, in the process, influenced both tobacco and alcohol use disorders.